These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28844780)

  • 1. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience.
    Chan DTM; Yi-Pin Sonia H; Poon WS
    Asian J Surg; 2018 Sep; 41(5):467-472. PubMed ID: 28844780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
    Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
    World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
    Rapp M; Kamp M; Steiger HJ; Sabel M
    World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results.
    Tykocki T; Michalik R; Bonicki W; Nauman P
    Neurol Neurochir Pol; 2012; 46(1):47-51. PubMed ID: 22426762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
    Haider SA; Lim S; Kalkanis SN; Lee IY
    J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.
    Roberts DW; Valdés PA; Harris BT; Fontaine KM; Hartov A; Fan X; Ji S; Lollis SS; Pogue BW; Leblond F; Tosteson TD; Wilson BC; Paulsen KD
    J Neurosurg; 2011 Mar; 114(3):595-603. PubMed ID: 20380535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note.
    Morshed RA; Han SJ; Lau D; Berger MS
    J Neurosurg; 2018 May; 128(5):1448-1453. PubMed ID: 28665248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
    Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
    J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image guided surgery for the resection of brain tumours.
    Barone DG; Lawrie TA; Hart MG
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009685. PubMed ID: 24474579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.
    Ewelt C; Floeth FW; Felsberg J; Steiger HJ; Sabel M; Langen KJ; Stoffels G; Stummer W
    Clin Neurol Neurosurg; 2011 Sep; 113(7):541-7. PubMed ID: 21507562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.
    Lau D; Hervey-Jumper SL; Han SJ; Berger MS
    J Neurosurg; 2018 May; 128(5):1410-1418. PubMed ID: 28731401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced resection of primary high-grade gliomas using a combination of intraoperative magnetic resonance imaging and intraoperative fluorescence (5-aminolevulinic acid): A single-centre experience.
    Sharma V; Kedia R; Narang KS; Jha AN
    Neurol India; 2018; 66(3):747-752. PubMed ID: 29766937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(9):1-92. PubMed ID: 32194883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.
    Colditz MJ; Jeffree RL
    J Clin Neurosci; 2012 Nov; 19(11):1471-4. PubMed ID: 22959448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Aminolevulinic Acid Imaging of Malignant Glioma.
    Li G; Rodrigues A; Kim L; Garcia C; Jain S; Zhang M; Hayden-Gephart M
    Surg Oncol Clin N Am; 2022 Oct; 31(4):581-593. PubMed ID: 36243495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence guided surgery by 5-ALA and intraoperative MRI in high grade glioma: a systematic review.
    Coburger J; Wirtz CR
    J Neurooncol; 2019 Feb; 141(3):533-546. PubMed ID: 30488293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas.
    Stummer W; Stepp H; Wiestler OD; Pichlmeier U
    Neurosurgery; 2017 Aug; 81(2):230-239. PubMed ID: 28379547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
    Chohan MO; Berger MS
    J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To what extent will 5-aminolevulinic acid change the face of malignant glioma surgery?
    Díez Valle R; Tejada Solis S
    CNS Oncol; 2015; 4(4):265-72. PubMed ID: 26118538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.